*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ The/DT inspector/NN general/NN 's/POS office/NN ]
of/IN 
[ the/DT Health/NNP ]
and/CC 
[ Human/NNP Services/NNPS Department/NNP ]
said/VBD 
[ it/PRP ]
is/VBZ conducting/VBG 
[ a/DT criminal/JJ investigation/NN ]
of/IN 
[ Bolar/NNP Pharmaceutical/NNP Co./NNP ]
for/IN 
[ possible/JJ ]
``/`` 
[ false/JJ information/NN ]
''/'' concerning/VBG 
[ applications/NNS ]
to/TO manufacture/VB at/IN 
[ least/JJS two/CD generic/JJ drugs/NNS ]
and/CC 
[ other/JJ matters/NNS ]
./. 

======================================

[ The/DT investigation/NN ]
was/VBD confirmed/VBN by/IN 
[ Judy/NNP Holtz/NNP ]
,/, 
[ a/DT spokeswoman/NN ]
at/IN 
[ the/DT inspector/NN general/NN 's/POS office/NN ]
./. 

======================================

[ She/PRP ]
said/VBD 
[ the/DT case/NN ]
has/VBZ been/VBN discussed/VBN with/IN 
[ the/DT U.S./NNP attorney/NN 's/POS office/NN ]
in/IN 
[ Baltimore/NNP ]
,/, 
[ which/WDT ]
has/VBZ been/VBN leading/VBG 
[ a/DT criminal/JJ probe/NN ]
of/IN 
[ the/DT generic/JJ drug/NN industry/NN ]

[ that/WDT ]
has/VBZ already/RB resulted/VBN in/IN 
[ several/JJ convictions/NNS ]
./. 

======================================

But/CC so/RB far/RB ,/, 
[ she/PRP ]
said/VBD ,/, 
[ the/DT U.S./NNP attorney/NN has/VBZ n't/RB ]
decided/VBN to/TO act/VB on/IN 
[ the/DT case/NN ]
,/, and/CC 
[ the/DT case/NN has/VBZ n't/RB ]
been/VBN presented/VBN to/TO 
[ a/DT grand/JJ jury/NN ]
./. 

======================================

On/IN 
[ news/NN ]
of/IN 
[ the/DT investigation/NN ]
on/IN 
[ the/DT Dow/NNP Jones/NNP Professional/NNP Investor/NNP Report/NNP news/NN wire/NN ]
,/, 
[ Bolar/NNP shares/NNS ]
fell/VBD 
[ $/$ 1.875/CD ]
to/TO 
[ $/$ 17/CD ]
in/IN 
[ American/NNP Stock/NNP Exchange/NNP composite/JJ ]
trading/NN on/IN 
[ volume/NN ]
of/IN 
[ 1.2/CD million/CD shares/NNS ]
./. 

======================================

Specifically/RB ,/, 
[ Ms./NNP Holtz/NNP ]
said/VBD 
[ the/DT criminal/JJ investigation/NN ]
involves/VBZ 
[ possible/JJ false/JJ information/NN ]
concerning/VBG 
[ Bolar/NNP 's/POS drug/NN applications/NNS ]
for/IN 
[ its/PRP$ version/NN ]
of/IN 
[ Dyazide/NNP ]
,/, 
[ a/DT blood/NN pressure/NN medicine/NN ]
,/, and/CC 
[ its/PRP$ version/NN ]
of/IN 
[ Macrodantin/NNP ]
,/,  
[ a/DT urinary/JJ tract/NN antibiotic/NN ]
./. 

Together/RB ,/, 
[ those/DT two/CD drugs/NNS ]
represent/VBP 
[ an/DT estimated/VBN 50/CD %/NN ]
of/IN 
[ Bolar/NNP 's/POS annual/JJ sales/NNS ]
./. 

======================================

[ Bolar/NNP ]
also/RB is/VBZ under/IN 
[ investigation/NN ]
about/IN 
[ circumstances/NNS ]
surrounding/VBG 
[ the/DT company/NN 's/POS use/NN ]
of/IN 
[ a/DT brand/NN name/NN anti-psychotic/JJ drug/NN ]
as/IN 
[ Bolar/NNP 's/POS product/NN ]
in/IN 
[ outside/JJ laboratory/NN testing/NN ]
in/IN 
[ 1982/CD ]
./. 

However/RB ,/, 
[ FDA/NNP spokesman/NN Jeff/NNP Nesbit/NNP ]
said/VBD 
[ he/PRP ]
believed/VBD 
[ the/DT criminal/JJ statute/NN ]
of/IN 
[ limitation/NN ]
had/VBD already/RB expired/VBN and/CC that/IN 
[ Bolar/NNP ]
could/MD n't/RB be/VB charged/VBN in/IN 
[ connection/NN ]
with/IN 
[ that/DT drug/NN testing/NN ]
./. 

[ The/DT company/NN ]
has/VBZ said/VBD 
[ that/DT ]
was/VBD 
[ an/DT inadvertent/JJ mix-up/NN ]
./. 

======================================

On/IN 
[ Monday/NNP ]
,/, 
[ Bolar/NNP President/NNP Robert/NNP Shulman/NNP ]
said/VBD 
[ the/DT company/NN ]
had/VBD n't/RB been/VBN informed/VBN that/IN 
[ it/PRP ]
was/VBD 
[ the/DT target/NN ]
of/IN 
[ a/DT criminal/JJ probe/NN ]
./. 

[ Ms./NNP Holtz/NNP ]
said/VBD 
[ Mr./NNP Shulman/NNP ]
was/VBD interviewed/VBN 
[ Tuesday/NNP ]
by/IN 
[ an/DT investigator/NN ]
from/IN 
[ the/DT inspector/NN general/NN 's/POS office/NN ]
and/CC 
[ a/DT representative/NN ]
of/IN 
[ the/DT Food/NNP ]
and/CC 
[ Drug/NNP Administration/NNP ]
./. 

======================================

[ Yesterday/NN Mr./NNP Shulman/NNP ]
was/VBD out/IN of/IN 
[ the/DT country/NN ]
on/IN 
[ business/NN ]
and/CC could/MD n't/RB be/VB reached/VBN ./. 

[ Patricia/NNP Shukri/NNP ]
,/, 
[ vice/NN president/NN ]
at/IN 
[ Bolar/NNP ]
,/, said/VBD 
[ an/DT outside/JJ lawyer/NN ]
for/IN 
[ the/DT company/NN ]
learned/VBD of/IN 
[ the/DT probe/NN ]
yesterday/NN but/CC did/VBD n't/RB get/VB 
[ any/DT details/NNS ]
./. 

======================================

[ Gary/NNP Jordan/NNP ]
,/, 
[ an/DT assistant/NN U.S./NNP attorney/NN ]
in/IN 
[ Baltimore/NNP ]
in/IN 
[ charge/NN ]
of/IN 
[ the/DT generic/JJ drug/NN probe/NN ]
,/, declined/VBD to/TO comment/VB about/IN 
[ Bolar/NNP ]
./. 

[ He/PRP ]
said/VBD 
[ his/PRP$ office/NN ]
has/VBZ 
[ a/DT policy/NN ]
of/IN not/RB confirming/VBG or/CC denying/VBG 
[ criminal/JJ investigations/NNS ]
./. 

======================================

Earlier/RB 
[ this/DT week/NN Bolar/NNP ]
voluntarily/RB recalled/VBD 
[ its/PRP$ 100mg/JJ version/NN ]
of/IN 
[ the/DT urinary/JJ tract/NN antibiotic/NN ]
,/, then/RB 
[ it/PRP ]
expanded/VBD 
[ the/DT recall/NN ]
to/TO 
[ the/DT 50mg/JJ capsules/NNS ]
of/IN 
[ the/DT same/JJ drug/NN ]
./. 

Combined/VBN ,/, 
[ those/DT two/CD versions/NNS ]
of/IN 
[ Macrodantin/NNP ]
represent/VBP about/IN 
[ 10/CD %/NN ]
of/IN 
[ Bolar/NNP 's/POS total/JJ annual/JJ sales/NNS ]
./. 

======================================

[ Macrodantin/NNP ] 
is/VBZ made/VBN by/IN 
[ Norwich/NNP Eaton/NNP ]
,/, 
[ a/DT unit/NN ]
of/IN 
[ Procter/NNP ]
&/CC 
[ Gamble/NNP Co./NNP ]
of/IN 
[ Cincinnati/NNP ]
./. 

======================================

[ Bolar/NNP ]
had/VBD said/VBN 
[ the/DT FDA/NNP ]
presented/VBD 
[ evidence/NN ]
suggesting/VBG that/IN 
[ Bolar/NNP ]
passed/VBD off/RP 
[ Macrodantin/NNP ]
as/IN 
[ its/PRP$ own/JJ ]
to/TO obtain/VB 
[ government/NN clearance/NN ]
to/TO market/VB 
[ a/DT generic/JJ version/NN ]
./. 

[ Bolar/NNP ]
denied/VBD 
[ the/DT accusation/NN ]
and/CC said/VBD 
[ an/DT outside/JJ firm/NN ]
would/MD audit/VB 
[ its/PRP$ drug/NN applications/NNS ]
to/TO clear/VB 
[ the/DT matter/NN ]
./. 

======================================

As/IN previously/RB reported/VBN ,/, 
[ the/DT FDA/NNP ]
issued/VBD 
[ a/DT statement/NN ]
in/IN 
[ August/NNP ]
saying/VBG 
[ it/PRP ]
did/VBD n't/RB have/VB 
[ any/DT evidence/NN ]
of/IN 
[ fraud/NN ]
in/IN 
[ Bolar/NNP ]

[ 's/POS application/NN ]
for/IN 
[ its/PRP$ version/NN ]
of/IN 
[ Dyazide/NNP ]
,/, 
[ which/WDT ]
is/VBZ made/VBN by/IN 
[ SmithKline/NNP Beecham/NNP PLC/NNP ]
./. 

======================================

Afterwards/RB ,/, however/RB ,/, 
[ FDA/NNP Commissioner/NNP Frank/NNP Young/NNP ]
said/VBD 
[ Bolar/NNP ]
had/VBD n't/RB been/VBN exonerated/VBN of/IN 
[ suspicions/NNS ]
that/IN 
[ it/PRP ]
substituted/VBD 
[ the/DT brand/NN name/NN product/NN ]
as/IN 
[ its/PRP$ own/JJ ]
to/TO gain/VB 
[ governmental/JJ approval/NN ]
to/TO market/VB 
[ a/DT generic/JJ version/NN ]
of/IN 
[ Dyazide/NNP ]
./. 

[ Mr./NNP Nesbit/NNP ]
,/, 
[ the/DT FDA/NNP spokesman/NN ]
,/, said/VBD 
[ the/DT agency/NN ]
continues/VBZ to/TO investigate/VB ./. 

======================================

[ Bolar/NNP ]

[ 's/POS version/NN ]
of/IN 
[ Dyazide/NNP ]
remains/VBZ 
[ the/DT sole/JJ generic/JJ ]
on/IN 
[ the/DT market/NN ]
,/, but/CC 
[ the/DT FDA/NNP ]
has/VBZ downgraded/VBN 
[ the/DT product/NN ]
so/IN that/IN 
[ it/PRP ]
's/VBZ 
[ no/DT ]
longer/RB considered/VBN 
[ the/DT therapeutic/JJ equivalent/NN ]
of/IN 
[ the/DT SmithKline/NNP product/NN ]
./. 
